SecBot SecBot
3 ·Filed Oct 13, 2026

RTSN

Retension Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 21h ago SEC0001213900-26-109153
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a standard initial beneficial ownership filing with no trading activity or material change. Monitor future Form 4 filings for any open-market purchases or sales by Cheruvu, which could signal insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
RTSN ▲ +28.87% at T+5d
NEUTRAL call +28.87% · α vs SPY +28.41% · entry $11.64 → $15.00
Next anchor: T+20d in 15d
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
+4.90%
call +4.90% · α +4.61%
$12.21
settled 12d ago
T+5d
+28.87%
call +28.87% · α +28.41%
$15.00
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Pavan Cheruvu filed a Form 3 initial statement of beneficial ownership with Retension Pharmaceuticals, Inc., appointing Alex Schwartz as attorney-in-fact for Section 16 reporting. This is a routine administrative filing by a new insider and contains no financial data or material corporate events.

Key Facts

  • Pavan Cheruvu filed Form 3 as a reporting owner of Retension Pharmaceuticals, Inc. (ticker: RTSN).
  • Cheruvu appointed Alex Schwartz as attorney-in-fact to prepare and file Section 16 reports.
  • The filing is dated October 13, 2026, with a period of report of October 13, 2026.
  • No securities ownership amounts or transactions are disclosed in the filing.

Financial Impact

No financial impact — the filing is a procedural insider registration with no disclosed holdings or transactions.

Risk Factors

  • No material risks identified from this filing alone.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001213900-26-109153
Document: 0001213900-26-109153-index-headers.html0001213900-26-109153
Document: 0001213900-26-109153-index.html0001213900-26-109153
Document: 0001213900-26-109153.txt0001213900-26-109153
18 reports for RTSN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RTSN — sortable, filterable
TypeNow
Oct 22, 2026
3d ago
8-K
NEUTRAL ★ 2/10
$16.55awaiting T+5—$14.55 (−12.11%)
Oct 16, 2026
9d ago
SC 13G
NEUTRAL ★ 4/10
$16.33awaiting T+5—$14.55 (−10.93%)
Oct 16, 2026
10d ago
SC 13G
NEUTRAL ★ 3/10
$14.07 $15.25▲ +8.39%▲ +8.82%$14.55 (+3.38%)
Oct 15, 2026
11d ago
SC 13G
NEUTRAL ★ 3/10
$12.21 $15.50▲ +26.95%▲ +27.96%$14.55 (+19.12%)
Oct 14, 2026
11d ago
SC 13D
NEUTRAL ★ 3/10
$12.21 $15.50▲ +26.95%▲ +27.96%$14.55 (+19.12%)
Oct 13, 2026
12d ago
Insider Cluster
BULLISH ★ 5/10
$11.64 $15.00▲ +28.87%▲ +28.41%$14.55 (+24.96%)
Oct 13, 2026
12d ago
3
NEUTRAL ★ 2/10
$11.64 $15.00▲ +28.87%▲ +28.41%$14.55 (+24.96%)
Oct 9, 2026
16d ago
424B4
NEUTRAL ★ 5/10
$11.32 $16.33▲ +44.26%▲ +45.75%$14.55 (+28.49%)
Oct 9, 2026
17d ago
EFFECT
BULLISH ★ 7/10
$10.53 $14.07▲ +33.62%▲ +35.59%$14.55 (+38.13%)
Oct 8, 2026
17d ago
3
NEUTRAL ★ 2/10
$10.53 $14.07▲ +33.62%▲ +35.59%$14.55 (+38.13%)
Showing 10 of 18

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026